Medicare Enrolled

Dr. Dustin Thrash, MD

Internal Medicine · Dallas, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
3607 OAK LAWN AVE, Dallas, TX 75219
4699414212
In practice since 2007 (18 years)
NPI: 1225249220 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Thrash from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Thrash? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Thrash

Dr. Dustin Thrash is an internal medicine in Dallas, TX, with 18 years in practice. Based on federal Medicare data, Dr. Thrash performed 6,569 Medicare services across 3,099 unique beneficiaries.

Between the years covered by Open Payments, Dr. Thrash received a total of $21,839 from 54 pharmaceutical and/or device companies across 1151 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Thrash is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 5% volume in TX$ $21,839 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,569
Medicare services
Top 5% in TX for internal medicine
3,099
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~365 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Destruction of precancerous skin growths, 2-142,524$5$23
Office visit, established patient (20-29 min)1,016$64$297
Destruction of precancerous skin growth, 1643$30$223
Destruction of skin growths (warts/lesions), 1-14444$87$378
Skin biopsy, tangential429$65$338
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)266$301$1,275
Application of light to destroy precancer skin growth239$100$466
Biopsy of related skin growth, each additional growth209$41$168
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm146$235$1,011
New patient office visit (30-44 min)114$74$369
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm68$103$813
Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm63$253$1,052
Destruction of precancer skin growth, 15 or more growths61$122$562
Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm54$109$889
Destruction of skin growth, 15 or more growths40$91$441
Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm33$103$839
Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm32$104$927
Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm25$233$1,031
Biopsy of ear24$51$321
Office visit, established patient (30-39 min)23$99$420
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less19$193$878
Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm17$70$572
Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm15$120$1,045
Injection into skin growth, 1-7 growths14$45$190
Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less14$216$946
Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm13$64$521
Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm13$111$983
Steroid injection (triamcinolone)11$1$24
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$21,839
Total received (2018-2024)
Avg $3,120/year across 7 years
Top 4% in TX for internal medicine
54
Companies
1,151
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,189 (92.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$845 (3.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$805 (3.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,254
2023
$3,328
2022
$3,855
2021
$3,760
2020
$2,047
2019
$2,356
2018
$3,239

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AbbVie Inc.
$2,232
Lilly USA, LLC
$1,783
ABBVIE INC.
$1,626
Novartis Pharmaceuticals Corporation
$1,180
Sun Pharmaceutical Industries Inc.
$1,117
AbbVie, Inc.
$1,087
GENZYME CORPORATION
$1,082
Medimetriks Pharmaceuticals, Inc.
$883
Regeneron Healthcare Solutions, Inc.
$870
SUN PHARMACEUTICAL INDUSTRIES INC.
$858
Encore Dermatology Inc.
$721
Dermavant Sciences, Inc.
$708
PFIZER INC.
$693
Journey Medical Corporation
$603
Arcutis Biotherapeutics, Inc.
$593
Janssen Biotech, Inc.
$549
LEO Pharma Inc.
$503
Galderma Laboratories, L.P.
$482
Ortho Dermatologics, a division of Bausch Health US, LLC
$436
MAYNE PHARMA INC.
$413
Incyte Corporation
$409
Almirall LLC
$390
UCB, Inc.
$265
Mayne Pharma Inc.
$246
Amgen Inc.
$243
EPI Health, LLC
$192
VYNE Pharmaceuticals Inc.
$185
Exeltis, USA Inc.
$164
DUSA Pharmaceuticals, Inc.
$148
Allergan, Inc.
$142
E.R. Squibb & Sons, L.L.C.
$139
Glenmark Therapeutics Inc.
$103
Biofrontera Inc.
$84
MAYNE PHARMA COMMERCIAL LLC
$81
REVANCE THERAPEUTICS, INC.
$76
DERMIRA, INC.
$60
Sebela Pharmaceuticals Inc.
$55
Aclaris Therapeutics, Inc.
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$41
Sandoz Inc.
$40
Mylan Pharmaceuticals Inc.
$38
Helsinn Therapeutics (U.S.), Inc.
$36
Tactile Systems Technology Inc
$33
Allergan Inc.
$27
Fidia Pharma USA Inc.
$26
Taro Pharmaceuticals USA, Inc.
$24
Novum Pharma, LLC
$20
Mission Pharmacal Company
$18
Blueprint Medicines Corporation
$18
Kyowa Kirin, Inc.
$16
Paratek Pharmaceuticals, Inc.
$15
Verrica Pharmaceuticals Inc.
$13
Celgene Corporation
$12
PruGen, Inc. Pharmaceuticals
$8
Top 3 companies account for 25.8% of total payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Aczone · Alcortin A · Avar · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX · BOTOX COSMETIC · BRYHALI · Bimzelx · CLODERM · COSENTYX · Cabtreo · Ceracade · Cimzia · Clindacin ETZ · Clindamycin Phosphate and Benzoyl Peroxide · Cordran Tape · DAXXIFY · DORYX · DUOBRII · DUPIXENT · EBGLYSS · ELIDEL · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Ecoza · Enbrel · Exelderm · Flexitouch Plus · Genadur · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · JUBLIA EFINACONAZOLE · KERYDIN · Klisyri · LEVULAN KERASTICK · LIBTAYO · LUZU LULICONAZOLE · Mupirocin Cream · NAFTIN · NUZYRA · Neo-Synalar · Neo-Synalar Cream · Neo-Synalar Cream Kit · Neocera · ODOMZO · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Odomzo · Olux · Otezla · PRAMOSONE · Poteligeo · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOLODYN · SOOLANTRA · SPEVIGO · Seysara · Sitavig · Skyrizi · Sotyktu · Sumadan Kit · TALTZ · TREMFYA · TargaDox · Tremfya · ULTRAVATE · USP) 0.1% · VALCHLOR · VTAMA · Veltin · Winlevi · XOLAIR · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for internal medicine in TX.

Equivalent to $332 per 100 Medicare services performed
Looking for a internal medicine in Dallas?
Compare internal medicines in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse internal medicines nearby

Geographic Context

Internal Medicines within 10 mi
2,180
Per 100K population
83.7
County median income
$74,149
Nearest hospital
TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Thrash is a clinical cardiology specialist, with above-average Medicare volume (top 5% in TX), and high industry engagement (low-engagement, top 4%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Thrash experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Thrash performed 2,524 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Thrash receive payments from pharmaceutical companies?
Yes. Dr. Thrash received a total of $21,839 from 54 companies across 1,151 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Thrash's costs compare to other internal medicines in Dallas?
Dr. Thrash's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Thrash) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →